Products & Services · Revenues:

Sulperazon (Outside the U.S. and Canada) — Revenues:

Pfizer Sulperazon (Outside the U.S. and Canada) — Revenues: increased by 17.8% to $199.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.3%, from $164.00M to $199.00M. Over 4 years (FY 2021 to FY 2025), Sulperazon (Outside the U.S. and Canada) — Revenues: shows relatively stable performance with a -1.1% CAGR.

Analysis

StatementSegment
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_sulperazon_outside_the_u_s_and_canada_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$141.00M$181.00M$168.00M$210.00M$210.00M$178.00M$188.00M$320.00M$177.00M$122.00M$138.00M$167.00M$144.00M$156.00M$169.00M$164.00M$166.00M$154.00M$169.00M$199.00M
QoQ Change—+28.4%-7.2%+25.0%+0.0%-15.2%+5.6%+70.2%-44.7%-31.1%+13.1%+21.0%-13.8%+8.3%+8.3%-3.0%+1.2%-7.2%+9.7%+17.8%
YoY Change————+48.9%-1.7%+11.9%+52.4%-15.7%-31.5%-26.6%-47.8%-18.6%+27.9%+22.5%-1.8%+15.3%-1.3%+0.0%+21.3%
Range$122.00M – $320.00M
CAGR+7.5%
Avg YoY Growth+3.5%
Median YoY Growth-0.6%
Current Streak2 quarters growth

Frequently Asked Questions

What is Pfizer's sulperazon (outside the u.s. and canada) — revenues:?
Pfizer (PFE) reported sulperazon (outside the u.s. and canada) — revenues: of $199.00M in Q1 2026.
How has Pfizer's sulperazon (outside the u.s. and canada) — revenues: changed year-over-year?
Pfizer's sulperazon (outside the u.s. and canada) — revenues: increased by 21.3% year-over-year, from $164.00M to $199.00M.
What is the long-term trend for Pfizer's sulperazon (outside the u.s. and canada) — revenues:?
Over 4 years (2021 to 2025), Pfizer's sulperazon (outside the u.s. and canada) — revenues: has grown at a -1.1% compound annual growth rate (CAGR), from $682.00M to $653.00M.